TOYO Co., Ltd delivered a deep third-quarter miss. It earned $0.10 per share against a $0.31 consensus, a 67.7% shortfall, and revenue of $129.04 million came in 8.6% below the $141.15 million estimate. Earnings fell from $0.66 a year ago, and net income dropped to $4.3 million from $22.6 million. The central development is not the miss itself but what caused it. The Commerce Department's circumvention inquiry into Ethiopian-made cells has effectively removed TOYO's most profitable business from the U.S. market. Meanwhile, the newer Houston module franchise is scaling quickly but cannot yet replace those economics.
The quality of the quarter deteriorated sharply beneath a revenue line that looks only modestly weaker. Revenue fell 4.8% year over year but rose 9.2% sequentially. Third-party revenue jumped 57.3% to $112.1 million, while related-party revenue collapsed to $17.0 million from $64.3 million. The mix shift was punishing. Gross margin fell to 16.6%, down from 31.3% in the second quarter, 33.5% in the first quarter and 25.7% a year earlier. Operating costs made it worse: general and administrative expense more than tripled year over year to $14.4 million, which the call tied to legal and professional fees from the trade proceedings. Operating income shrank to $5.2 million from $28.8 million. Net income has now stepped down from $28.4 million in Q1 to $17.4 million in Q2 to $4.3 million in Q3, a three-quarter slide that shows the damage building rather than a one-off disruption.
The guidance picture is where bears have the most ammunition. Earlier in the year, management laid out FY26 targets of 5.5-5.8 GW of cells, 1.0-1.3 GW of modules and $90-100 million of adjusted net income, and expressed confidence in them as recently as the first-quarter call. Those targets were not reaffirmed in Q2. Now the company is declining to provide any revenue, net income or cell guidance, citing a dynamic policy environment. With nine-month adjusted net income at $50.7 million, the original target is effectively out of reach. Cash also deserves scrutiny. The release shows cash and restricted cash of $74.0 million, up from $58.9 million at year-end. The call analysis, however, puts the June 30 figure at $123.4 million. Nine-month operating cash flow of $35.2 million, versus $61.4 million through the first half, implies a meaningful Q3 operating outflow. Inventory roughly doubled to $165.3 million and receivables climbed to $71.0 million. The year-to-date cash gain leaned on roughly $52.6 million of equity raised through a registered direct offering and an at-the-market program, and the share count has swelled to 42.7 million from 35.3 million a year ago.
The call did preserve a credible growth story on the module side. Houston nameplate capacity reached about 2 GW with the second line, roughly on the timeline management had targeted. TOYO has signed about $240 million of binding module contracts since mid-June, delivering through the first half of 2027. Management said 2027 capacity is more than 80% committed, at pricing in the mid-30s cents per watt for the first half and high-30s for the second half, with 2028 discussions at 40-45 cents. Contract liabilities from third parties rose to $123.7 million from $27.6 million, which is consistent with customer prepayments backing that demand. Non-FEOC cell supply from outside Ethiopia is secured for committed deliveries through 2027, all CBP detentions have been released, and new wafer sales added $24.3 million. The first 45X tax credit, for tax year 2025, has been approved, and none of it was included in Q3 margins.
The near-term catalyst calendar is dense and binary. Commerce's preliminary circumvention determination is expected around December 10-17, though management flagged possible delays from understaffing. TOYO has also submitted a Section 232 offset proposal and says it is near the front of the queue, with approvals expected from early December into the first quarter of 2027. The $357 million HJT cell line remains a large funding question. Its pilot timing has drifted to "no later than" the first quarter of 2028.
The market has priced in much of this distress. Shares were at $4.64 heading into the report, up just 3.1% from the open after the August release. That leaves the stock 41% below its 200-day moving average of $7.86. The stock set a 52-week low of $3.71 on October 28, rallied to $5.56 by November 9, and has since given back part of that move. Investor sentiment, already slightly negative, weakened further from -0.06 to -0.13, a meaningful but not dramatic deterioration. Short-term trend readings are mixed, with price and momentum neutral and AVWAP positive, reflecting the rebound off the lows rather than any fundamental repair.
The bottom line is that TOYO's quarter was worse than the revenue line suggests. Margins collapsed, the full-year guidance has been abandoned, and Q3 operating cash flow apparently turned negative. The forward case now rests on a module business that is filling its 2027 book at rising prices and on December trade rulings that could either restore or permanently impair the cell franchise. Investors are left holding a policy-dependent bet rather than a visible earnings stream.